Stephen George Dilly, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 61,197 shares at $33.19 ($2.0M) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $2.0M AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.59 | 58,699 | $1.9M | 95.8% |
| 2 | $33.19 | 2,498 | $83K | 4.2% |
| Total | $32.61 avg | 61,197 | $2.0M | 100% |
| Filing → |
| SRRA | BUY | 2021-05-20 | $178K | — | Filing → |
| SGMO | SELL | 2020-03-20 | $210K | — | Filing → |
| SGMO | SELL | 2020-03-18 | $90K | — | Filing → |